Technical Analysis for CPH - Cipher Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade D 1.15 1.77% 0.020
CPH closed up 1.77 percent on Tuesday, September 22, 2020, on 67 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Flat
Historical CPH trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction 1.77%
Down 3 Days in a Row Weakness 1.77%
20 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Fell Below 20 DMA Bearish -0.86%
Crossed Above 20 DMA Bullish -2.54%
Older End-of-Day Gignals for CPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.
Medicine RTT Organ Systems Psoriasis Acne Actinic Keratosis Rheumatoid Arthritis

Is CPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.68
52 Week Low 0.38
Average Volume 21,875
200-Day Moving Average 1.080
50-Day Moving Average 1.286
20-Day Moving Average 1.147
10-Day Moving Average 1.153
Average True Range 0.044
ADX 25.89
+DI 15.084
-DI 27.374
Chandelier Exit (Long, 3 ATRs ) 1.119
Chandelier Exit (Short, 3 ATRs ) 1.231
Upper Bollinger Band 1.187
Lower Bollinger Band 1.107
Percent B (%b) 0.54
BandWidth 6.975
MACD Line -0.031
MACD Signal Line -0.039
MACD Histogram 0.0073
Fundamentals Value
Market Cap 30.61 Million
Num Shares 26.6 Million
EPS -1.34
Price-to-Earnings (P/E) Ratio -0.86
Price-to-Sales 2.68
Price-to-Book 7.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.165
Resistance 3 (R3) 1.163 1.157 1.163
Resistance 2 (R2) 1.157 1.153 1.158 1.162
Resistance 1 (R1) 1.153 1.150 1.155 1.155 1.161
Pivot Point 1.147 1.147 1.148 1.148 1.147
Support 1 (S1) 1.143 1.143 1.145 1.145 1.139
Support 2 (S2) 1.137 1.140 1.138 1.138
Support 3 (S3) 1.133 1.137 1.138
Support 4 (S4) 1.135